BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10603572)

  • 1. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective.
    Dunne DW; Pearce EJ
    Microbes Infect; 1999 Jun; 1(7):553-60. PubMed ID: 10603572
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of immune complexes in ascitic fluid of hepatosplenic schistosomiasis.
    Khalil HM; Makled MK; el Sebai MM; el Naggar MK
    J Egypt Soc Parasitol; 1987 Dec; 17(2):699-705. PubMed ID: 3121767
    [No Abstract]   [Full Text] [Related]  

  • 3. An ultrastructural study of hepatic granulomas and schistosome egg shells in murine hepatosplenic schistosomiasis mansoni.
    Stenger RJ; Warren KS; Johnson EA
    Exp Mol Pathol; 1967 Aug; 7(1):116-32. PubMed ID: 5006463
    [No Abstract]   [Full Text] [Related]  

  • 4. T cell-dependent immunodepression in vivo in Schistosoma mansoni infected patients.
    Muniz-Junqueira MI; Tosta CE; Prata A
    Rev Soc Bras Med Trop; 1990; 23(1):27-31. PubMed ID: 2128545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
    Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
    Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni.
    Mwatha JK; Kimani G; Kamau T; Mbugua GG; Ouma JH; Mumo J; Fulford AJ; Jones FM; Butterworth AE; Roberts MB; Dunne DW
    J Immunol; 1998 Feb; 160(4):1992-9. PubMed ID: 9469463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatosplenic schistosomiasis mansoni: an immunologic disease.
    Warren KS
    Bull N Y Acad Med; 1975 Apr; 51(4):545-50. PubMed ID: 1091317
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific treatment of hepatosplenic schistosomiasis can increase T-lymphocyte reactivity.
    Muniz-Junqueira MI; Tavares-Neto J; Ataide M; Prata A; Tosta CE
    Rev Soc Bras Med Trop; 1991; 24(2):97-9. PubMed ID: 1841433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic schistosomiasis.
    McKerrow JH; Sun E
    Prog Liver Dis; 1994; 12():121-35. PubMed ID: 7746870
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological changes in splenectomized versus non splenectomized schistosomal hepatosplenic cases.
    Salem SA; Makled MK; Abel-Wahab MF; Sedky A; Montasser MF; Bishara SA; Ragheb MM; Younis TA
    J Egypt Soc Parasitol; 1987 Dec; 17(2):785-96. PubMed ID: 3121771
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral immune responses in human hepatosplenic schistosomiasis mansoni.
    Goodgame RW; Colley DG; Draper CC; Lewis FA; McLaren ML; Pelley RP
    Am J Trop Med Hyg; 1978 Nov; 27(6):1174-80. PubMed ID: 727322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of Schistosoma mansoni isolated from patients with hepatosplenic and intestinal clinical forms of schistosomiasis.
    de Lima e Costa MF; Roche RS; Katz N
    Am J Trop Med Hyg; 1984 Sep; 33(5):918-23. PubMed ID: 6486301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An electron microscopic study of the liver parenchyma and schistosome pigment in murine hepatosplenic schistosomiasis mansoni.
    Stenger RJ; Warren KS; Johnson EA
    Am J Trop Med Hyg; 1967 Jul; 16(4):473-82. PubMed ID: 5006467
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical immunology of hepato-splenic bilharziasis].
    Esterre P; Boisier P; Ravaolimalala VA; Roux J
    Arch Inst Pasteur Madagascar; 1994; 61(1):28-30. PubMed ID: 7778947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatosplenic schistosomiasis mansoni: a tragic disease].
    de Oliveira-e-Silva A; D'Albuquerque LA
    Arq Gastroenterol; 2003; 40(4):201-2. PubMed ID: 15264039
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet function and the von Willebrand factor antigen in the hepatosplenic form of schistosomiasis mansoni.
    Correia MC; Domingues AL; Lacerda HR; Santos EM; Machado CG; Hora V; Neves MA; Brito A; Coêlho MR; Silva JL
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1053-8. PubMed ID: 19118853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological and immunofluorescence study of the choroid plexus in hepatosplenic schistosomiasis mansoni.
    Pittella JE; Bambirra EA
    Am J Trop Med Hyg; 1989 Nov; 41(5):548-52. PubMed ID: 2510526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects and imaging patterns with ultrasonography and endoscopy in hepatosplenic schistosomiasis in Uganda.
    Ravera M; Reggiori A; Cocozza E; Andreata M; Ciantia F; Riccioni G
    East Afr Med J; 1996 Apr; 73(4):228-32. PubMed ID: 8706604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levels of anti-typhoid agglutinins in patients with hepatosplenic schistosomiasis].
    Yasuda MA; Ferri RG; Yasuda PH; Netto CF; da Silva GR; Ferreira JM
    Rev Saude Publica; 1982 Apr; 16(2):107-13. PubMed ID: 7146817
    [No Abstract]   [Full Text] [Related]  

  • 20. Schistosomal granuloma modulation. III. Schistosma haematobium worms accelerate S. mansoni soluble egg antigen-induced hepatic granuloma formation in vivo.
    Jacobs W; Deelder A; Bogers J; Van de Vijver K; Van Marck E
    Parasitol Res; 1999 Nov; 85(11):905-9. PubMed ID: 10540951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.